Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-09

Clinical Trial Update: INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE [Phase 4]

View source ↗

Summary

Phase 4 trial comparing indobufen against aspirin for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Indobufen (indobufen)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Indobufen | Phase 4 | Status: COMPLETED